Division of Molecular Medicine and Gene Therapy
41 – 50 of 618
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response
- Contribution to journal › Article
-
Mark
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
- Contribution to journal › Article
-
Mark
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
- Contribution to journal › Article
-
Mark
Hematopoietic cells emerging from hemogenic endothelium exhibit lineage-specific oxidative stress responses
- Contribution to journal › Article
-
Mark
Reprogramming Stars #19 : Upgrading Cell Fate Conversions with Engineered Reprogramming Factors-An Interview with Dr. Ralf Jauch
- Contribution to journal › Article
-
Mark
Prdm16 amplifies Notch signaling and suppresses venous lineage specification to prevent arteriovenous malformations during vascular development
(2024)
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Reprogramming Stars #17 : Breaking Down the Barriers of Direct Reprogramming Using a Model Organism-An Interview with Dr. Baris Tursun
(2024) In Cellular Reprogramming
- Contribution to journal › Debate/Note/Editorial
-
Mark
Chromosome-Scale Genome Assembly Reveals How Repeat Elements Shape Non-Coding RNA Landscapes Active During Newt Limb Regeneration
(2024)
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Osteopontin : A Key Multifaceted Regulator in Tumor Progression and Immunomodulation
- Contribution to journal › Scientific review
- 2023
-
Mark
Best Practices to Promote Data Utility and Reuse by the Non-Traditional Model Organism Community
- Contribution to journal › Article
